Barclays PLC Lowers Stake in Owens & Minor, Inc. (NYSE:OMI)

Barclays PLC reduced its position in Owens & Minor, Inc. (NYSE:OMI) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 132,189 shares of the company’s stock after selling 1,513 shares during the quarter. Barclays PLC owned approximately 0.17% of Owens & Minor worth $1,727,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of OMI. Sterling Capital Management LLC raised its stake in Owens & Minor by 758.3% in the fourth quarter. Sterling Capital Management LLC now owns 2,060 shares of the company’s stock valued at $27,000 after buying an additional 1,820 shares in the last quarter. Blue Trust Inc. lifted its holdings in shares of Owens & Minor by 57.4% during the fourth quarter. Blue Trust Inc. now owns 4,387 shares of the company’s stock worth $57,000 after purchasing an additional 1,600 shares during the period. KBC Group NV lifted its stake in shares of Owens & Minor by 98.2% in the 4th quarter. KBC Group NV now owns 4,434 shares of the company’s stock worth $58,000 after acquiring an additional 2,197 shares during the period. Optimize Financial Inc acquired a new position in Owens & Minor during the 4th quarter worth approximately $184,000. Finally, Inspire Advisors LLC grew its holdings in Owens & Minor by 11.2% during the fourth quarter. Inspire Advisors LLC now owns 15,350 shares of the company’s stock worth $201,000 after acquiring an additional 1,548 shares during the period. Institutional investors and hedge funds own 98.04% of the company’s stock.

Insider Activity

In other news, major shareholder Coliseum Capital Management, L acquired 1,738,511 shares of the firm’s stock in a transaction that occurred on Friday, February 28th. The stock was purchased at an average price of $9.39 per share, for a total transaction of $16,324,618.29. Following the completion of the acquisition, the insider now owns 9,469,698 shares in the company, valued at $88,920,464.22. This trade represents a 22.49 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Over the last ninety days, insiders acquired 2,718,412 shares of company stock worth $24,495,308. 3.69% of the stock is owned by corporate insiders.

Owens & Minor Price Performance

NYSE OMI opened at $7.46 on Friday. Owens & Minor, Inc. has a 1 year low of $6.07 and a 1 year high of $23.87. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The company has a market cap of $575.94 million, a PE ratio of -11.47, a PEG ratio of 0.20 and a beta of 1.02. The stock’s 50-day moving average price is $8.23 and its two-hundred day moving average price is $11.03.

Owens & Minor (NYSE:OMI) last released its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping analysts’ consensus estimates of $0.53 by $0.02. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The firm had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same quarter in the previous year, the business earned $0.69 EPS. The business’s revenue was up 1.5% on a year-over-year basis. On average, analysts predict that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor announced that its Board of Directors has initiated a share buyback plan on Friday, February 28th that permits the company to repurchase $100.00 million in outstanding shares. This repurchase authorization permits the company to buy up to 13.6% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research firms have commented on OMI. JPMorgan Chase & Co. decreased their target price on Owens & Minor from $14.00 to $10.00 and set an “underweight” rating on the stock in a research report on Monday, March 10th. UBS Group lowered their price objective on Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, February 13th. Robert W. Baird increased their target price on Owens & Minor from $10.00 to $11.00 and gave the stock a “neutral” rating in a research report on Monday, March 3rd. Finally, Citigroup decreased their price objective on shares of Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a research note on Thursday, April 17th. Two analysts have rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $12.50.

Owens & Minor Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.